This webinar will present strategies and tools for doing a complete and comprehensive impact assessment of supplier change notices. Tools and procedures for deciding if full impact assessments need to be processed and when notices for lower impact changes can be accepted or rejected without a full assessment will be discussed. Who (what skill sets) should be on the impact assessment team, how often to meet and methods for evaluating change notices will also be discussed. Supplier agreements and quality agreements with suppliers and vendors as well as using risk based approaches to impact assessments will be highlighted.
WHY SHOULD YOU ATTEND?
Any manufacturer of pharmaceutical products or medical devices will have vendors and suppliers in order to acquire the materials needed for manufacturing product. In a regulated environment, the manufacturer is responsible for the quality and source of all incoming materials. When supplier or vendors make changes to material, its own manufacturing or supplier they should tell the manufacturer about these changes via a supplier change notice. Without proper evaluation of the change, unforeseen changes could occur in the product leading to failed manufacturing runs or the release of non-conforming material to market. Regulatory agencies (FDA) expect manufactures to be in control of all incoming material, therefore failure to do a proper impact assessment of supplier changes could also lead to enforcement action and/or product recall. Manufactures need a robust process ensure all vendors and suppliers provide change notices and to evaluate all notices for impact.
AREA COVERED
- Introduction to supplier change notices
- Regulatory impact of supplier change notices
- Risk based approach to categorizing supplier change notices
- Key skill sets needed to evaluate supplier change notices
- Verification and Validation of supplier change notices
- Key tools to help in impact assessments of supplier change notices
LEARNING OBJECTIVES
- Understanding supplier change notices
- Categorization of change notices based on risk
- Setting up a change impact team
- Supplier/vendor quality agreements and supplier agreements
- What happens if the change is unacceptable
- How to set up incoming material specifications
WHO WILL BENEFIT?
- QA professionals
- Technical scientists
- Production staff
- Regulatory Affairs professionals
- Supply chain professionals
Any manufacturer of pharmaceutical products or medical devices will have vendors and suppliers in order to acquire the materials needed for manufacturing product. In a regulated environment, the manufacturer is responsible for the quality and source of all incoming materials. When supplier or vendors make changes to material, its own manufacturing or supplier they should tell the manufacturer about these changes via a supplier change notice. Without proper evaluation of the change, unforeseen changes could occur in the product leading to failed manufacturing runs or the release of non-conforming material to market. Regulatory agencies (FDA) expect manufactures to be in control of all incoming material, therefore failure to do a proper impact assessment of supplier changes could also lead to enforcement action and/or product recall. Manufactures need a robust process ensure all vendors and suppliers provide change notices and to evaluate all notices for impact.
- Introduction to supplier change notices
- Regulatory impact of supplier change notices
- Risk based approach to categorizing supplier change notices
- Key skill sets needed to evaluate supplier change notices
- Verification and Validation of supplier change notices
- Key tools to help in impact assessments of supplier change notices
- Understanding supplier change notices
- Categorization of change notices based on risk
- Setting up a change impact team
- Supplier/vendor quality agreements and supplier agreements
- What happens if the change is unacceptable
- How to set up incoming material specifications
- QA professionals
- Technical scientists
- Production staff
- Regulatory Affairs professionals
- Supply chain professionals
Speaker Profile
Alan M Golden has over 30 years of experience in the medical device industry, both in basic research and quality assurance. Alan spent 31 years at Abbott Laboratories. For the first 16 years as part of diagnostics R&D, he developed recombinant proteins used in diagnostics tests, received three US patents, and published numerous papers and abstracts. Alan then transitioned to a quality assurance role wherein both the Abbott Diagnostics and Abbott Molecular divisions, he was responsible for quality assurance for new product development, on-market product support, and operations.Alan’s quality assurance experience extends from design control, change control, risk …
Upcoming Webinars
A Modest PMBOK® Guide Proposal: Project Blame Management (S…
AI-Powered Onboarding: How to Personalize, Streamline the N…
Marketing to Medicare or Medicaid Beneficiaries - What You …
Effective Onboarding: How to Welcome, Engage, and Retain Ne…
2-Hour Virtual Seminar on the 6 Most Common Problems in FDA…
So, You’re Now the “Boss”: Essential Skills to Succeed as a…
Outlook - Master your Mailbox - Inbox Hero Inbox Zero
Managing Toxic & Other Employees Who Have Attitude Issues
FDA Compliance And Laboratory Computer System Validation
Tips and Techniques for Conducting an Effective Fraud Risk …
Managing Complex Projects - Project Management
21 CFR Part 820 - Quality System Regulation - Applying Prin…
Design Verification, Validation and Testing for Medical Dev…
Harassment, Bullying, Gossip, Confrontational and Disruptiv…
Performance Management: Dealing With The Difficult Employee
Treasury Risk Management, Funding, Liquidity, Interest Rate…
OSHA Requirements for Supervisors, Project Leaders & HR - W…
California Meal and Rest Breaks: What You Don't Know Can Co…
Essential Job Functions According to the American with Disa…
Improving Employee Engagement & Retention Through Stay Inte…
FFIEC BSA/AML Examination Manual: What Compliance Officers …
HIPAA Bootcamp for Health Care Providers, Professionals, an…
Dealing With Difficult People In Life & Work
Conquer Toxic People - Learn To Protect Yourself And Get Yo…
Introduction to Generative AI for Accountants
Updated Metro 2®, e-OSCAR and the New Tougher FCRA/CFPB Com…
3-Hour Virtual Seminar on Excel Deep Dive: Advanced Tips & …
Surviving and Thriving Organizational Change and Loss: The …
How to Write Effective Audit Observations: The Principles f…
Impact Assessment and Risk Management for Change Control
Coming Soon - New Minimum Salary Levels for Exempt Employee…
Stressed Out: How to Handle Conflict, Difficult People and …
Marijuana: Compliance and Safety in the Workplace
FDA Regulation of Artificial Intelligence/ Machine Learning
Data Integrity: Compliance with 21 CFR Part 11, SaaS-Cloud,…
How to Give Corrective Feedback: The CARE Model - Eliminati…
SOPs - How to Write Them to Satisfy those Inspectors
Why EBITDA Doesn't Spell Cash Flow and What Does
Documenting Misconduct that Will Stand Up in Court
With Mandatory Paid Leave Gaining Ground Is It Time To Do A…
Tattoos, hijabs, piercings, and pink hair: The challenges …
Onboarding is NOT Orientation - How to Improve the New Empl…
Excel Power Skills: Master Functions, Formulas, and Macros …